Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells
about
A clinical-molecular update on azanucleoside-based therapy for the treatment of hematologic cancersOn the potential role of DNMT1 in acute myeloid leukemia and myelodysplastic syndromes: not another mutated epigenetic driver.Rapamycin restores p14, p15 and p57 expression and inhibits the mTOR/p70S6K pathway in acute lymphoblastic leukemia cells.
P2860
Consequences of combining siRNA-mediated DNA methyltransferase 1 depletion with 5-aza-2'-deoxycytidine in human leukemic KG1 cells
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Consequences of combining siRN ...... ne in human leukemic KG1 cells
@ast
Consequences of combining siRN ...... ne in human leukemic KG1 cells
@en
type
label
Consequences of combining siRN ...... ne in human leukemic KG1 cells
@ast
Consequences of combining siRN ...... ne in human leukemic KG1 cells
@en
prefLabel
Consequences of combining siRN ...... ne in human leukemic KG1 cells
@ast
Consequences of combining siRN ...... ne in human leukemic KG1 cells
@en
P2093
P2860
P356
P1433
P1476
Consequences of combining siRN ...... ne in human leukemic KG1 cells
@en
P2093
Arthur Deroide
Cécile Desjobert
Didier Cussac
Emeline Davoine
Fabrice Lestienne
Florence Busato
Jérôme Besse
Luc De Vries
Lucie Fournier
Natacha Novosad
P2860
P304
15265-15282
P356
10.18632/ONCOTARGET.3317
P407
P577
2015-06-01T00:00:00Z